Compare Flex Ltd (FLEX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flex Ltd vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Flex Ltd trades at $116.85 (market cap $44.09B), while Halozyme Therapeutics Inc. Common Stock trades at $109.88 (market cap $12.58B). The key difference: Flex Ltd is far larger — about 3.5× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Flex Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 3 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FLEX | HALO | |
|---|---|---|
Market Cap | $44.09B | $12.58B |
Volume | 3,022,166 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $162.07 | $115.22 |
52-Week Low | $54.51 | $61.63 |
Typical Hold Time | 3 Days | 0 Days |
Enterprise Value | $47.18B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flex Ltd
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
